The number of 700’000 AMR deaths p.a. worldwide is increasing constantly and estimated to reach up to 10 million AMR deaths p.a. worldwide by 2050.
The post-antibiotic era has become reality. The changing reimbursement options generate opportunities for our start-up. Selmod aims for business opportunity in a re-emerging market.